# FDA Inspection 605751 - GBA Pharma GmbH - July 30, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/gba-pharma-gmbh/dbb6130b-3d6e-4e47-9023-7701c2d1bc55
Source feed: FDA_Inspections

> FDA Inspection 605751 for GBA Pharma GmbH on July 30, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 605751
- Company Name: GBA Pharma GmbH
- Inspection Date: 2009-07-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1128748 - 2020-07-09](https://www.globalkeysolutions.net/records/fda_inspections/gba-pharma-gmbh/1dca0385-bd54-42c0-9eff-436ed2af78e2)
- [FDA Inspection 961236 - 2016-01-29](https://www.globalkeysolutions.net/records/fda_inspections/gba-pharma-gmbh/b65a6fa3-23a5-4d38-9941-10f31563d636)

Company: https://www.globalkeysolutions.net/companies/gba-pharma-gmbh/e7a5bc51-6bd9-457a-b251-fcaba7152284

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c